Multiple signals regulate phospholipase CBeta3 in human myometrial cells.

Multiple signals regulate phospholipase CBeta3 in human myometrial cells.
复制标题

DOI:
10.1095/biolreprod.107.064485
复制
发表时间:
2008-06
影响因子:
3.6
通讯作者:
M. Zhong;D. Murtazina;J. Phillips;C. Ku;B. Sanborn
M. Zhong;D. Murtazina;J. Phillips;C. Ku;B. Sanborn
中科院分区:
生物学2区
文献类型:
--
作者:
M. Zhong;D. Murtazina;J. Phillips;C. Ku;B. Sanborn

文献摘要

被引文献

相似文献

磷脂酶CB 3(PLCB 3)丝氨酸(1105)(S(1105))是多种蛋白激酶的底物,代表了子宫肌层中几种信号通路的潜在汇聚点。为了探索这一假设,在永生化和原代人子宫肌层细胞中研究了PLCB 3-S(1105)磷酸化(P-S(1105))的调节。8-[4-氯苯硫基](CPT)-cAMP和降钙素基因相关肽(CALCA)短暂增加P-S(1105)。松弛素也刺激P-S(1105);这种作用被蛋白激酶A(PRKA)抑制剂Rp-8-CPT-cAMPS部分阻断。催产素,刺激Galphaq介导的途径,也迅速增加P-S(1105),前列腺素F2 α和ATP也是如此。催产素刺激的磷酸化被蛋白激酶C(PRKC)抑制剂Go 6976阻断,并通过用佛波酯预处理过夜。氯氰菊酯(一种PP 2B磷酸酶抑制剂)延长了CALCA对P-S的作用(1105),而冈田酸(一种PP 1/PP 2A抑制剂)则没有延长,而催产素刺激的P-S增加则相反(1105)。PLCB 3是子宫肌层细胞中表达的主要PLC同种型,PLCB 3短发夹RNA构建体显著减弱催产素刺激的细胞内钙增加。催产素诱导的磷脂酰肌醇(PI)的营业额被抑制CPT-cAMP和冈田酸,但增强预处理与Go 6976。CPT-cAMP在存在过表达的PLCB 3的情况下抑制催产素刺激的PI转换,但不存在过表达的PLCB 3-S(1105)A。这些数据表明,来自cAMP/PRKA途径的负串扰和涉及PRKC的催产素/G蛋白/PLCB途径中的负反馈环在子宫肌层细胞中起作用,并表明不同的蛋白磷酸酶在介导这些途径中的P-S(1105)去磷酸化中占主导地位。PLCB 3水平上的多个信号成分的整合可能对其在子宫肌层中的功能很重要。
Phospholipase CB3 (PLCB3) serine(1105) (S(1105)), a substrate for multiple protein kinases, represents a potential point of convergence of several signaling pathways in the myometrium. To explore this hypothesis, the regulation of PLCB3-S(1105) phosphorylation (P-S(1105)) was studied in immortalized and primary human myometrial cells. 8-[4-chlorophenylthio] (CPT)-cAMP and calcitonin gene-related peptide (CALCA) transiently increased P-S(1105). Relaxin also stimulated P-S(1105); this effect was partially blocked by the protein kinase A (PRKA) inhibitor, Rp-8-CPT-cAMPS. Oxytocin, which stimulates Galphaq-mediated pathways, also rapidly increased P-S(1105), as did prostaglandin F2alpha and ATP. Oxytocin-stimulated phosphorylation was blocked by protein kinase C (PRKC) inhibitor Go6976 and by pretreatment overnight with a phorbol ester. Cypermethrin, a PP2B phosphatase inhibitor, but not okadaic acid, a PP1/PP2A inhibitor, prolonged the effect of CALCA on P-S(1105), whereas the reverse was the case for the oxytocin-stimulated increase in P-S(1105). PLCB3 was the predominant PLC isoform expressed in the myometrial cells and PLCB3 short hairpin RNA constructs significantly attenuated oxytocin-stimulated increases in intracellular calcium. oxytocin-induced phosphatidylinositol (PI) turnover was inhibited by CPT-cAMP and okadaic acid, but was enhanced by pretreatment with Go6976. CPT-cAMP inhibited oxytocin-stimulated PI turnover in the presence of overexpressed PLCB3, but not overexpressed PLCB3-S(1105)A. These data demonstrate that both negative crosstalk from the cAMP/PRKA pathway and a negative feedback loop in the oxytocin/G protein/PLCB pathway involving PRKC operate in myometrial cells and suggest that different protein phosphatases predominate in mediating P-S(1105) dephosphorylation in these pathways. The integration of multiple signal components at the level of PLCB3 may be important to its function in the myometrium.